Teva Reports Results of Strategic Review, Sees 14 Pipeline Projects Possible for Divestment, Discontinuation

By: via Benzinga
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced the results of its strategic review of core therapeutic areas for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.